Interactions Between Probiotic and Oral Pathogenic Strains
Overview
Affiliations
More than 6 billion bacteria and other microorganisms live in the adult oral cavity. As a result of any deleterious effect on this community, some microorganisms will survive better than others, which may trigger pathogenic processes like caries, halitosis, gingivitis or periodontitis. Oral dysbiosis is among the most frequent human health hazards globally. Quality of life of patients deteriorates notably, while treatments are often unpleasant, expensive and irreversible, e.g. tooth loss. In the experiments reported here, we investigated the individual interactions between 8 pathogenic and 8 probiotic strains and a commercially available probiotic product. Almost all pathogens, namely Fusobacterium nucleatum, Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Streptococcus oralis, Streptococcus gordonii, Enterococcus faecalis and Prevotella buccae are pathogens frequently occurring in the oral cavity. The used probiotic strains were Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus delbrueckii, Bifidobacterium thermophilum and two Streptococcus dentisani isolates. Using a modified agar diffusion method, we investigated capability of the probiotic bacteria to prevent the growth of the pathogenic ones in order to identify candidates for future therapeutic treatments. The results indicated successful bacteriocin production, i.e. growth inhibition, against every pathogenic bacterium by at least 5 probiotic strains.
Sweet Orange Juice Processing By-Product Extracts: A Caries Management Alternative to Chlorhexidine.
Saha S, Boesch C, Maycock J, Wood S, Do T Biomolecules. 2023; 13(11).
PMID: 38002290 PMC: 10669069. DOI: 10.3390/biom13111607.
Babina K, Salikhova D, Doroshina V, Makeeva I, Zaytsev A, Uvarichev M Nutrients. 2023; 15(18).
PMID: 37764667 PMC: 10535351. DOI: 10.3390/nu15183882.
Mechanism of Action of , a New Bacterial Species with Probiotic Potential.
Martinez-Lamas L, Garcia-Mato E, Rincon-Quintero A, Rivas-Mundina B, Diz-Dios P, Alvarez-Fernandez M Antibiotics (Basel). 2023; 12(9).
PMID: 37760768 PMC: 10525679. DOI: 10.3390/antibiotics12091472.
Qureshi A, Connolly J Malar J. 2023; 22(1):234.
PMID: 37580703 PMC: 10426224. DOI: 10.1186/s12936-023-04665-5.
Zanetta P, Squarzanti D, Coste A, Amoruso A, Pane M, Azzimonti B Biomedicines. 2023; 11(3).
PMID: 36979838 PMC: 10045872. DOI: 10.3390/biomedicines11030859.